Enzolytics Inc (ENZC)

[fb454]

What I see as a very important point in today`s PR from Samsung is; This is taken from the PR.{ CURE }
Under the terms of the agreement, Samsung Biologics will provide end-to-end
CDMO services from cell line development, clinical drug substance, and drug
product manufacturing services to support IND filings for Anti-HIV and
Anti-SARS-CoV-2 Monoclonal Antibodies for the treatment of HIV and SARS-CoV-2.
In addition, there will be continuing discussions for other Monoclonal
Antibodies being developed by Enzolytics.

The Enzolytics protocol offers the opportunity to implement A.I. analysis and
provides a platform for creating multiple fully human Monoclonal Antibodies
targeting conserved immutable sites on the virus and offering a cure for these
viruses. A stable cell line will be manufactured with support from Samsung
Biologics' R&D Center in San Francisco. Its related clinical trial materials
will be manufactured at Samsung Biologics headquarters in Incheon, South
Korea.